Melanie Meersch-Dini

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

Biomarkers for the Prediction and Judgement of Sepsis and Sepsis Complications: A Step towards precision medicine?

Melanie Meersch-Dini, Thilo von Groote, 2022, Journal of clinical medicine.

Interleukin 24 promotes cell death in renal epithelial cells and is associated with acute renal injury

A. Zarbock, H. Pavenstädt, S. Reuter, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Corticotropin-stimulated steroid profiles to predict shock development and mortality in sepsis: From the HYPRESS study

D. Annane, J. Briegel, C. Putensen, 2022, Critical Care.

[Quality improvement measures in the care of critically ill intensive care patients with renal replacement therapy for acute kidney injury : Position paper of the Kidney Section of DIVI in collaboration with DGAI and DGIIN].

A. Zarbock, P. Heering, M. Oppert, 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

The AKI care bundle: all bundle components are created equal—are they?

L. Forni, A. Hoffmeier, J. Kellum, 2021, Intensive Care Medicine.

Acute kidney injury

L. Forni, M. Joannidis, Melanie Meersch-Dini, 2023, Intensive Care Medicine.

When the kidneys hurt, the other organs suffer

M. Joannidis, C. Monard, Melanie Meersch-Dini, 2022, Intensive Care Medicine.